Proteonomix, Inc. is a biotechnology company, which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. It develops pre-clinical stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Paramus, NJ.